GGrantIndex
← Leaderboards

Melanie A Simpson

University Of Minnesota Twin Cities

$3,771,456
Attributed
$3,997,283
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $654.7K · FY200516
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$3,997,283 · 10

By mechanism

R01$2,689,792 · 2
P20$757,706 · 5
R21$333,178 · 1
T32$118,477 · 1
F32$98,130 · 1

Top collaborators

Most similar at University Of Minnesota Twin Cities

Same institution · by research overlap

Others in their field

Top investigators on “Neoplastic Cell

Research focus

Neoplastic CellProductionProstateHyaluronanEnzymesHyaluronidaseTumor ProgressionNeoplasm MetastasisTissuesProstatic NeoplasmsCell MotilityCancer PatientGlycosaminoglycansMalignant Neoplasm Of ProstatePolymersHyaluronan Synthase 1Cell GrowthPreventCell ProliferationInjection Of Therapeutic AgentGrowthDensityPathway InteractionsResponse

Grant awards (27)

Mechanisms of Hyaluronan Signaling and Turnover in Prostate Cancer$220,316
R01 · FY2016 · CA · contact PI
Defining aberrant steroid elimination in castration resistant prostate cancer$101,812
R21 · FY2016 · CA · contact PI
Mechanisms of Hyaluronan Signaling and Turnover in Prostate Cancer$80,742
R01 · FY2016 · CA · contact PI
Mechanisms of Hyaluronan Signaling and Turnover in Prostate Cancer$50,641
R01 · FY2016 · CA · contact PI
Defining aberrant steroid elimination in castration resistant prostate cancer$48,954
R21 · FY2016 · CA · contact PI
Mechanisms of Hyaluronan Signaling and Turnover in Prostate Cancer$303,131
R01 · FY2015 · CA · contact PI
Defining aberrant steroid elimination in castration resistant prostate cancer$182,412
R21 · FY2015 · CA · contact PI
Molecular Mechanisms of Disease$118,477
T32 · FY2015 · GM · contact PI
Mechanisms of Hyaluronan Signaling and Turnover in Prostate Cancer$50,641
R01 · FY2015 · CA · contact PI
Mechanisms of Hyaluronan Signaling and Turnover in Prostate Cancer$299,643
R01 · FY2014 · CA · contact PI
Mechanisms of Hyaluronan Signaling and Turnover in Prostate Cancer$290,622
R01 · FY2013 · CA · contact PI
Mechanisms of Hyaluronan Signaling and Turnover in Prostate Cancer$309,172
R01 · FY2012 · CA · contact PI
HYALURONAN TURNOVER IN PROSTATE CANCER$73,498
P20 · FY2011 · RR · contact PI
Role of hyaluronan matrix in prostate cancer progression$28,675
R01 · FY2010 · CA · contact PI
Role of hyaluronan matrix in prostate cancer progression$205,583
R01 · FY2009 · CA · contact PI
REDOX COORDINATED EXTRACELLULAR MATRIX REMODELING IN CANCER$28,080
P20 · FY2009 · RR · contact PI
Role of hyaluronan matrix in prostate cancer progression$205,583
R01 · FY2008 · CA · contact PI
REDOX COORDINATED EXTRACELLULAR MATRIX REMODELING IN CANCER$70,426
P20 · FY2008 · RR · contact PI
Role of hyaluronan matrix in prostate cancer progression$205,583
R01 · FY2007 · CA · contact PI
Role of hyaluronan matrix in prostate cancer progression$222,642
R01 · FY2006 · CA · contact PI
COBRE: UNL: ADMINISTRATIVE CORE$48,246
P20 · FY2006 · RR · contact PI
COBRE: UNL: P5: PRODUCTION OF HYALURONAN IN PROSTATE TUMORIGENESIS$252,941
P20 · FY2005 · RR
Role of hyaluronan matrix in prostate cancer progression$216,818
R01 · FY2005 · CA
COBRE: UNL: PRODUCTION OF HYALURONAN IN PROSTATE TUM$284,515
P20 · FY2004 · RR
HYALURONAN BIOSYNTHESIS IN PROSTATE CARCINOMA$18,618
F32 · FY2002 · CA
HYALURONAN BIOSYNTHESIS IN PROSTATE CARCINOMA$41,996
F32 · FY2001 · CA
HYALURONAN BIOSYNTHESIS IN PROSTATE CARCINOMA$37,516
F32 · FY2000 · CA